BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25882246)

  • 21. Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor agonists sabcomeline and xanomeline.
    Stengel PW; Cohen ML
    J Pharmacol Exp Ther; 2001 Mar; 296(3):818-24. PubMed ID: 11181912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.
    Noetzel MJ; Grant MK; El-Fakahany EE
    Neurochem Res; 2009 Jun; 34(6):1138-49. PubMed ID: 19082883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.
    Thomas RL; Mistry R; Langmead CJ; Wood MD; Challiss RA
    J Pharmacol Exp Ther; 2008 Nov; 327(2):365-74. PubMed ID: 18664591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.
    Noetzel MJ; Grant MK; El-Fakahany EE
    Pharmacology; 2009; 83(5):301-17. PubMed ID: 19401618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from Chinese hamster ovary-m1 cells.
    Eckols K; Bymaster FP; Mitch CH; Shannon HE; Ward JS; DeLapp NW
    Life Sci; 1995; 57(12):1183-90. PubMed ID: 7674807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.
    Jakubík J; Tucek S; El-Fakahany EE
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1033-41. PubMed ID: 12023535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
    Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
    Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
    Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.
    Li Z; Snigdha S; Roseman AS; Dai J; Meltzer HY
    Eur J Pharmacol; 2008 Oct; 596(1-3):89-97. PubMed ID: 18771666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biased Profile of Xanomeline at the Recombinant Human M
    McDonald JK; van der Westhuizen ET; Pham V; Thompson G; Felder CC; Paul SM; Thal DM; Christopoulos A; Valant C
    ACS Chem Neurosci; 2022 Apr; 13(8):1206-1218. PubMed ID: 35380782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activation.
    Spalding TA; Ma JN; Ott TR; Friberg M; Bajpai A; Bradley SR; Davis RE; Brann MR; Burstein ES
    Mol Pharmacol; 2006 Dec; 70(6):1974-83. PubMed ID: 16959945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor.
    Kane BE; Grant MK; El-Fakahany EE; Ferguson DM
    Bioorg Med Chem; 2008 Feb; 16(3):1376-92. PubMed ID: 17977730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M
    Maspero M; Volpato D; Cirillo D; Yuan Chen N; Messerer R; Sotriffer C; De Amici M; Holzgrabe U; Dallanoce C
    Bioorg Chem; 2020 Mar; 96():103633. PubMed ID: 32032848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.
    Woolley ML; Carter HJ; Gartlon JE; Watson JM; Dawson LA
    Eur J Pharmacol; 2009 Jan; 603(1-3):147-9. PubMed ID: 19111716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor.
    Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of partial agonists for the muscarinic m1 acetylcholine receptor.
    Chen X; Klöckner J; Holze J; Zimmermann C; Seemann WK; Schrage R; Bock A; Mohr K; Tränkle C; Holzgrabe U; Decker M
    J Med Chem; 2015 Jan; 58(2):560-76. PubMed ID: 25478907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M
    Popiolek M; Nguyen DP; Reinhart V; Edgerton JR; Harms J; Lotarski SM; Steyn SJ; Davoren JE; Grimwood S
    Biochemistry; 2016 Dec; 55(51):7073-7085. PubMed ID: 27958713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.
    Vogel WK; Sheehan DM; Schimerlik MI
    Mol Pharmacol; 1997 Dec; 52(6):1087-94. PubMed ID: 9415719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.